Agenus | AGEN - Loan Capital

Stock Price
3.39
Daily Change
-0.05 -1.45%
Monthly
1.50%
Yearly
111.88%
Q1 Forecast
3.45

Agenus reported $169.66M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Agenus USD 169.66M 146.06M Dec/2025
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
CSL USD 10.42B 273M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Intrexon USD 0 198.67M Jun/2024
J&J USD 39.44B 30M Dec/2025
Jiangsu Hengrui CNY 43.31M 8.11M Dec/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
MacroGenics USD 70M 256K Dec/2025
Merck EUR 10.73B 277M Dec/2025
Merck USD 39.97B 6B Sep/2025
Northwest Biotherapeutics USD 11.04M 4.7M Sep/2023
Novartis USD 29.59B 5.35B Dec/2025
Novavax USD 246.3M 200K Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
Veracyte USD 0 0 Mar/2025